Stage 4 Cancer: Life Expectancy, Treatments & Hope (2026)

What is Stage 4 Cancer?

Stage 4 cancer, also known as metastatic cancer, is the most advanced stage of cancer, where the disease has spread beyond its original site to other organs or tissues. The spread can occur through the bloodstream, lymphatic system, or direct extension. Grasping what stage 4 cancer involves is essential for understanding treatment options, prognosis, and managing expectations. Here, we explore the intricacies of stage 4 cancer, including diagnosis, treatment strategies, and how to maintain quality of life.

Life Expectancy and Prognosis

For the first time, most people diagnosed with cancer are expected to live at least five years beyond their diagnosis—a dramatic improvement from previous decades.

The improvements detailed in the organization’s Cancer Statistics 2026 report, recently published in CA: A Cancer Journal for Clinicians, highlight significant progress in cancer survival rates in the United States.
Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s.

In 2026, approximately 2,114,850 new cancer cases and 626,140 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2023, averting 4.8 million deaths since 1991, largely because of smoking reductions, earlier detection, and improved treatment. These interventions are also evident in rising 5-year relative survival, which reached a milestone 70% for diagnoses during 2015–2021 overall, 69% for regional-stage disease, and 35% for distant-stage (metastatic) disease, up from 63%, 54%, and 17%, respectively, in the mid-1990s. People with high-mortality cancers and advanced diagnoses had the largest gains, including increases from 32% to 62% for myeloma, 7% to 22% for liver cancer, 16% to 35% for metastatic melanoma, 8% to 18% for metastatic rectal cancer, 20% to 37% for regional lung cancer, and 2% to 10% for metastatic lung cancer. Nevertheless, lung cancer will cause more deaths in 2026 than second-ranking colorectal cancer and third-ranking pancreatic cancer combined. In summary, decades of scientific investment have translated to longer lives for people with even the most fatal cancers. (ACS 2026)

Life expectancy for stage 4 cancer varies widely depending on several factors, including:

• Type of Cancer: Different cancers have varying survival rates. For example, stage 4 breast cancer has a 5-year relative survival rate of around 30%, while stage 4 pancreatic cancer has a much lower rate.

• Extent of Spread: The number and location of metastases impact prognosis. Cancers that spread to vital organs like the lungs, liver, or brain tend to have a poorer outlook.

• Treatment Response: Some patients respond well to treatment, leading to longer survival times and improved quality of life.

• Overall Health: Patients with strong immune systems and fewer underlying health conditions may fare better.

• Advancements in Medicine: Targeted therapies, immunotherapy, and clinical trials are continually improving survival outcomes.

Stage 4 Cancer Life Expectancy

Stage 4 Breast Cancer Life expectancy

According to the American Cancer Society, the 5-year relative survival rate for Stage 4 breast cancer in women is 32%. This means 32% of women with Stage 4 breast cancer will still be living 5 years after diagnosis. (source)

Stage 4 Lung Cancer Life Expectancy

The relative 5-year survival rate for a person receiving a diagnosis of stage 4 small cell lung cancer (SCLS) is 3%, and 9% for stage 4 non-small cell lung cancer (NSCLC). (Medical News Today)

Stage 4 Colon Cancer Life Expectancy

The 5-year survival rate for people with stage 4 colon cancer is about 13%. (Medical News Today)

Stage 4 Pancreatic Cancer Life Expectancy

The five-year survival rate varies from around 2% to 12%, depending on age at diagnosis. (Verywell Health)

Stage 4 Prostate Cancer Life Expectancy

Unlike most prostate cancer diagnoses, for which the five-year survival rate is nearly 100 percent, the five-year survival rate for prostate cancer in the advanced stages may be less, depending on where the cancer has metastasized to. 

For instance, with regional metastasis (meaning the cancer has spread to nearby lymph nodes, muscles or organs), the five year survival rate is nearly 100 percent, but distant metastasis (meaning the cancer has spread to areas of the body beyond the pelvis), has a five-year survival rate of just 37 percent, according to the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database. 

Stage 4 Salivary Gland Cancer Life Expectancy

The 5-year survival rate for people with stage 4 salivary gland cancer is about 43%. (American Cancer Society)

To search life expectancy for other cancer types: SEER, National Cancer Institute

Treatment Options for Stage 4 Cancer

Although stage 4 cancer is typically not curable, several treatments aim to manage symptoms, slow disease progression, and improve quality of life:

1. Systemic Treatments

• Chemotherapy: Uses drugs to kill or slow cancer growth throughout the body.

• Targeted Therapy: Focuses on specific genetic markers in cancer cells to block their growth.

• Immunotherapy: Boosts the immune system to recognize and fight cancer cells.

• Hormone Therapy: Used in cancers like breast and prostate cancer to slow hormone-driven growth.

2. Localized Treatments

• Radiation Therapy: Shrinks tumors and alleviates symptoms like pain.

• Surgery: In select cases, removing metastatic tumors may improve survival and symptom management.

• Ablative Therapy: Techniques like cryoablation or radiofrequency ablation destroy cancer cells in targeted areas.

Living with Stage 4 Cancer: Hope & Quality of Life

Despite the challenges, many patients live meaningful lives with stage 4 cancer. Here are ways to enhance quality of life:

• Palliative Care: Helps manage pain, fatigue, and other symptoms while improving emotional well-being.

• Support Groups: Connecting with others facing similar challenges can provide emotional support.

• Clinical Trials: Some patients benefit from participating in cutting-edge research treatments.

• Healthy Lifestyle: Proper nutrition, gentle exercise, and stress management can make a difference.

Ivermectin and Fenbendazole for Stage 4 Cancer

Recent research has explored the potential of repurposing existing drugs, such as ivermectin, for cancer treatment. Originally an anti-parasitic medication, ivermectin has demonstrated promising anti-cancer properties in various studies. For instance, a 2024 study by Fan et al. found that ivermectin inhibits bladder cancer cell growth by inducing oxidative stress and DNA damage. Similarly, research by Li et al. in 2024 reported that ivermectin induces apoptosis in lung adenocarcinoma cells by downregulating PAK1. These findings suggest that ivermectin may offer a novel therapeutic approach for certain cancers. (onedaymd.com)

However, it's important to note that while these preliminary results are encouraging, ivermectin is not yet an approved standard treatment for cancer. Patients should consult with their healthcare providers before considering any off-label use of medications.

Incorporating emerging treatments like ivermectin into the broader context of stage 4 cancer care highlights the ongoing advancements in medical research. Staying informed about such developments can provide patients and their families with additional options to discuss with their medical teams.

Final Thoughts

A stage 4 cancer diagnosis is life-changing, but advancements in medicine provide hope for extended survival and better quality of life. Understanding available treatments, staying informed, and seeking support can help patients and their families navigate this journey with strength and resilience.


Related: Ivermectin, Fenbendazole, and Mebendazole for Stage 4 Cancer: Compilation of 250+ Case Reports (January 2026)